Skip to main content
Figure 2 | BMC Infectious Diseases

Figure 2

From: Empirical antifungal therapy with an echinocandin in critically-ill patients: prospective evaluation of a pragmatic Candida score-based strategy in one medical ICU

Figure 2

Organ failure kinetic expressed as global SOFA score value (panel A) and the cardiovascular SOFA score (panel B) daily measurements over the first week of treatment in the subset of patients (n = 30) who received empirical echinocandin therapy according to local guidelines without any proven IC thereafter. The patients were classified as “responders” if SOFA decreased by more than 1 point during the first 5 days of therapy (n = 18). Otherwise, they were considered as “non responders” (n = 12). D: day; SOFA: sequential organ failure assessment; IC: invasive candidiasis; R: responders; NR: non responders.

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us